Molecular Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellsworth, R. E.
Right arrow Articles by Shriver, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellsworth, R. E.
Right arrow Articles by Shriver, C. D.
Molecular Cancer Research 3:71-77 (2005)
© 2005 American Association for Cancer Research


Cancer Genes and Genomics

Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes1

Rachel E. Ellsworth, Darrell L. Ellsworth, David M. Neatrour, Brenda Deyarmin, Susan M. Lubert, Miranda J. Sarachine, Patrick Brown, Jeffrey A. Hooke and Craig D. Shriver

Clinical Breast Care Project, Windber Research Institute, Windber, Pennsylvania and Clinical Breast Care Project, Walter Reed Army Medical Center, Washington, District of Columbia

Requests for reprints: Rachel E. Ellsworth, Windber Research Institute, 600 Somerset Avenue, Windber, PA 15963. Phone: 814-467-9844; Fax: 814-467-6334. E-mail: rellswo{at}conemaugh.org

Axillary lymph node status is the most important prognostic factor in predicting disease outcome in women with breast cancer. A number of chromosomal aberrations in primary breast tumors have been correlated with lymph node status and clinical outcome, but chromosomal changes particular to metastatic lymph node tumors have not been well studied. DNA samples isolated from laser-microdissected primary breast and metastatic axillary lymph node tumors from 25 women with invasive breast cancer were amplified using 52 microsatellite markers defining 26 chromosomal regions commonly deleted in breast cancer. Levels and patterns of allelic imbalance (AI) within and between breast and lymph node tumors were assessed to identify chromosomal alterations unique to primary or metastatic tumors and to examine the timing of metastatic potential. The overall frequency of AI in primary breast tumors (0.24) was significantly greater (P < 0.001) than that in lymph node tumors (0.10), and congruent AI events were observed for <20% of informative markers. AI at chromosomes 11q23.3 and 17p13.3 occurred significantly more frequently (P < 0.05) in primary breast tumors alone; no chromosomal regions showed a significantly higher AI frequency in lymph nodes. Higher rates of AI in primary versus metastatic lymph node tumors suggest that acquisition of metastatic potential may be an early event in carcinogenesis, occurring before significant levels of AI accumulate in the primary tumor. In addition, patterns of AI were highly discordant between tumor types, suggesting that additional genetic alterations accumulated independently in the two cell populations.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
R. E. Ellsworth, D. L. Ellsworth, H. L. Patney, B. Deyarmin, J. A. Hooke, B. Love, and C. D. Shriver
Genomic Alterations Associated with Early Stages of Breast Tumor Metastasis
Ann. Surg. Oncol., July 1, 2008; 15(7): 1989 - 1995.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. E. Becker, R. E. Ellsworth, B. Deyarmin, H. L. Patney, R. M. Jordan, J. A. Hooke, C. D. Shriver, and D. L. Ellsworth
The Genomic Heritage of Lymph Node Metastases: Implications for Clinical Management of Patients with Breast Cancer
Ann. Surg. Oncol., April 1, 2008; 15(4): 1056 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. E. Ellsworth, D. L. Ellsworth, B. Love, H. L. Patney, L. R. Hoffman, J. Kane, J. A. Hooke, and C. D. Shriver
Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS
Ann. Surg. Oncol., November 1, 2007; 14(11): 3070 - 3077.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. A. Callaghan, T. E. Becker, D. L. Ellsworth, J. A. Hooke, R. E. Ellsworth, and C. D. Shriver
Genomic Instability and the Development of Metastatic Lymph Node Tumors
Ann. Surg. Oncol., November 1, 2007; 14(11): 3125 - 3132.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. S. Yan, C. Venkataramu, A. Ibrahim, J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y.-W. Leu, C. L. Shapiro, et al.
Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue.
Clin. Cancer Res., November 15, 2006; 12(22): 6626 - 6636.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.